NCT04236596View on ClinicalTrials.gov

Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

June 8, 2023

Study Completion Date

June 8, 2023

Conditions
Urinary RetentionUnderactive Bladder
Interventions
DEVICE

Participants received a Neurostimulator, which was used to map the pudendal nerve

Participants in study received neurostimulator at their pudendal nerve as part of their normal clinical care. This neurostimulator was used to map the nerve.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Michigan

OTHER

NCT04236596 - Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention | Biotech Hunter | Biotech Hunter